复发性尿路感染患者产生耐碳青霉烯ndm的大肠杆菌的分子特征。

IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Liang Chen, Zeqiang Xie, Jiyong Jian
{"title":"复发性尿路感染患者产生耐碳青霉烯ndm的大肠杆菌的分子特征。","authors":"Liang Chen, Zeqiang Xie, Jiyong Jian","doi":"10.7754/Clin.Lab.2024.241040","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to clarify the microbiological characteristics of carbapenem-resistant Escherichia coli (CRECO) due to New Delhi metallo-β-lactamase (NDM)-producing from recurrent urinary tract infection (RUTI) patients.</p><p><strong>Methods: </strong>CRECO isolates were isolated from the urine of RUTI patients, identified with VITEK 2 compact system, and confirmed by MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was performed with VITEK 2 compact system and Kirby-Bauer (K-B) method. Disk diffusion was used for extended spectrum beta-lactamase (ESBL) test. Phenotypic assays, including modified Hodge test (MHT), EDTA-modified carbapenem inactivation method (eCIM), and modified carbapenem inactivation method (mCIM), were performed to screen the carba-penemase. The antibiotic resistance genes were detected by polymerase chain reaction (PCR). Multilocus sequence typing (MLST) was performed for molecular typing of the strains.</p><p><strong>Results: </strong>Among 63 CRECO strains, 22 (34.9%) strains were NDM-positive, in which NDM-5 accounted for 68.2% (15/22), NDM-1 accounted for 22.7% (5/22), and NDM-3 accounted for 9.1% (2/22). Among the 22 strains, 20 (90.9%) strains were co-carrying ESBLs genes, 12 (54.6%) strains were co-carrying blaCTX and blaTEM, 8 (36.4%) strains were co-carrying blaCTX or blaTEM, and 5 strains were co-carrying AmpC genes. BlaCMY-6 and blaCMY-156 ac-counted for 9.1% (2/22) and blaCMY-42 and blaDHA-1 accounted for 4.5% (1/22). Ten (45.5%) strains were co-carrying quinolone resistance genes. Three (13.6%) strains were co-carrying colistin resistance genes mcr-1. Six (27.3%) strains showed OmpF-expressed loss. Fourteen strains were positive and 8 strains were negative in the MHT, but mCIM and eCIM were both positive; the results of double-disc synergy method for detection of ESBLs were all negative in NDM-positive CRECO strains. The NDM-producing CRECO strains showed high-resistant rate to most antibiotics.</p><p><strong>Conclusions: </strong>The antibiotic resistance mechanisms of NDM-positive CRECO are the coexistence of multiple resistance genes and/or the loss of or lesser expression of OMP. The emergence of mcr-1 gene in CRECO should be paid more attention by clinicians and microbiologists. Further surveillance should be strengthened to study the microbiological characteristics in order to control infection caused by NDM-positive CRECO better.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 5","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Molecular Characterization of Carbapenem-Resistant NDM-Producing Escherichia Coli from Recurrent Urinary Tract Infection Patients.\",\"authors\":\"Liang Chen, Zeqiang Xie, Jiyong Jian\",\"doi\":\"10.7754/Clin.Lab.2024.241040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>This study aimed to clarify the microbiological characteristics of carbapenem-resistant Escherichia coli (CRECO) due to New Delhi metallo-β-lactamase (NDM)-producing from recurrent urinary tract infection (RUTI) patients.</p><p><strong>Methods: </strong>CRECO isolates were isolated from the urine of RUTI patients, identified with VITEK 2 compact system, and confirmed by MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was performed with VITEK 2 compact system and Kirby-Bauer (K-B) method. Disk diffusion was used for extended spectrum beta-lactamase (ESBL) test. Phenotypic assays, including modified Hodge test (MHT), EDTA-modified carbapenem inactivation method (eCIM), and modified carbapenem inactivation method (mCIM), were performed to screen the carba-penemase. The antibiotic resistance genes were detected by polymerase chain reaction (PCR). Multilocus sequence typing (MLST) was performed for molecular typing of the strains.</p><p><strong>Results: </strong>Among 63 CRECO strains, 22 (34.9%) strains were NDM-positive, in which NDM-5 accounted for 68.2% (15/22), NDM-1 accounted for 22.7% (5/22), and NDM-3 accounted for 9.1% (2/22). Among the 22 strains, 20 (90.9%) strains were co-carrying ESBLs genes, 12 (54.6%) strains were co-carrying blaCTX and blaTEM, 8 (36.4%) strains were co-carrying blaCTX or blaTEM, and 5 strains were co-carrying AmpC genes. BlaCMY-6 and blaCMY-156 ac-counted for 9.1% (2/22) and blaCMY-42 and blaDHA-1 accounted for 4.5% (1/22). Ten (45.5%) strains were co-carrying quinolone resistance genes. Three (13.6%) strains were co-carrying colistin resistance genes mcr-1. Six (27.3%) strains showed OmpF-expressed loss. Fourteen strains were positive and 8 strains were negative in the MHT, but mCIM and eCIM were both positive; the results of double-disc synergy method for detection of ESBLs were all negative in NDM-positive CRECO strains. The NDM-producing CRECO strains showed high-resistant rate to most antibiotics.</p><p><strong>Conclusions: </strong>The antibiotic resistance mechanisms of NDM-positive CRECO are the coexistence of multiple resistance genes and/or the loss of or lesser expression of OMP. The emergence of mcr-1 gene in CRECO should be paid more attention by clinicians and microbiologists. Further surveillance should be strengthened to study the microbiological characteristics in order to control infection caused by NDM-positive CRECO better.</p>\",\"PeriodicalId\":10384,\"journal\":{\"name\":\"Clinical laboratory\",\"volume\":\"71 5\",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical laboratory\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7754/Clin.Lab.2024.241040\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:本研究旨在阐明复发性尿路感染(RUTI)患者产生新德里金属β-内酰胺酶(NDM)导致的碳青霉烯耐药大肠杆菌(CRECO)的微生物学特征。方法:从RUTI患者尿液中分离CRECO菌株,采用VITEK 2紧凑系统鉴定,MALDI-TOF ms确证,采用VITEK 2紧凑系统和Kirby-Bauer (K-B)法进行药敏试验。扩谱β -内酰胺酶(ESBL)检测采用纸片扩散法。采用改良霍奇试验(MHT)、edta改良碳青霉烯烯失活法(eCIM)和改良碳青霉烯失活法(mCIM)筛选碳青霉烯酶。采用聚合酶链反应(PCR)检测耐药基因。采用多位点序列分型(MLST)对菌株进行分子分型。结果:63株CRECO菌株中ndm阳性22株(34.9%),其中NDM-5占68.2% (15/22),NDM-1占22.7% (5/22),NDM-3占9.1%(2/22)。22株菌株中,共携带ESBLs基因20株(90.9%),共携带blaCTX和blaTEM 12株(54.6%),共携带blaCTX或blaTEM 8株(36.4%),共携带AmpC基因5株。BlaCMY-6和blaCMY-156占9.1% (2/22),blaCMY-42和blaDHA-1占4.5%(1/22)。10株(45.5%)共携带喹诺酮类耐药基因。3株(13.6%)共携带粘菌素耐药基因mcr-1。6株(27.3%)出现ompf表达缺失。MHT阳性14株,阴性8株,但mCIM和eCIM均为阳性;双盘协同法检测ndm阳性CRECO菌株的ESBLs均为阴性。产ndm的CRECO菌株对大多数抗生素具有较高的耐药率。结论:ndm阳性CRECO的耐药机制为多种耐药基因共存和/或OMP表达缺失或减少。mcr-1基因在CRECO中的出现应引起临床医生和微生物学家的高度重视。为了更好地控制ndm阳性CRECO引起的感染,应进一步加强监测,研究微生物学特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Molecular Characterization of Carbapenem-Resistant NDM-Producing Escherichia Coli from Recurrent Urinary Tract Infection Patients.

Background: This study aimed to clarify the microbiological characteristics of carbapenem-resistant Escherichia coli (CRECO) due to New Delhi metallo-β-lactamase (NDM)-producing from recurrent urinary tract infection (RUTI) patients.

Methods: CRECO isolates were isolated from the urine of RUTI patients, identified with VITEK 2 compact system, and confirmed by MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was performed with VITEK 2 compact system and Kirby-Bauer (K-B) method. Disk diffusion was used for extended spectrum beta-lactamase (ESBL) test. Phenotypic assays, including modified Hodge test (MHT), EDTA-modified carbapenem inactivation method (eCIM), and modified carbapenem inactivation method (mCIM), were performed to screen the carba-penemase. The antibiotic resistance genes were detected by polymerase chain reaction (PCR). Multilocus sequence typing (MLST) was performed for molecular typing of the strains.

Results: Among 63 CRECO strains, 22 (34.9%) strains were NDM-positive, in which NDM-5 accounted for 68.2% (15/22), NDM-1 accounted for 22.7% (5/22), and NDM-3 accounted for 9.1% (2/22). Among the 22 strains, 20 (90.9%) strains were co-carrying ESBLs genes, 12 (54.6%) strains were co-carrying blaCTX and blaTEM, 8 (36.4%) strains were co-carrying blaCTX or blaTEM, and 5 strains were co-carrying AmpC genes. BlaCMY-6 and blaCMY-156 ac-counted for 9.1% (2/22) and blaCMY-42 and blaDHA-1 accounted for 4.5% (1/22). Ten (45.5%) strains were co-carrying quinolone resistance genes. Three (13.6%) strains were co-carrying colistin resistance genes mcr-1. Six (27.3%) strains showed OmpF-expressed loss. Fourteen strains were positive and 8 strains were negative in the MHT, but mCIM and eCIM were both positive; the results of double-disc synergy method for detection of ESBLs were all negative in NDM-positive CRECO strains. The NDM-producing CRECO strains showed high-resistant rate to most antibiotics.

Conclusions: The antibiotic resistance mechanisms of NDM-positive CRECO are the coexistence of multiple resistance genes and/or the loss of or lesser expression of OMP. The emergence of mcr-1 gene in CRECO should be paid more attention by clinicians and microbiologists. Further surveillance should be strengthened to study the microbiological characteristics in order to control infection caused by NDM-positive CRECO better.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信